Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Health Care Compliance & Regulatory

Overview

Participants in the complex, heavily regulated health care industry must comply with an ever-changing framework of regulations. Leveraging legal, consulting, government advocacy and policy experience, we bring in-depth knowledge and real-world action plans to address the federal and state requirements that impact your organization’s growth, operations and ability to serve your patients and your communities. We help assess and mitigate regulatory and compliance risks, reduce exposure and resolve compliance issues. We guide you through fraud investigations, whistleblower lawsuits, Stark and Anti-Kickback Statute voluntary disclosures, Medicare and Medicaid reimbursement audits, investigations and voluntary refunds. We also assist with investigations and reporting of HIPAA and other privacy law breach issues, including ransomware and malware attacks. And, as the health care industry continues to enhance its digital presence, we advise on evolving regulatory issues regarding e health, telemedicine and other forms of remote health care service delivery.

Insights & Events

Latest

Updates February 2026

US and International Developments in Artificial Intelligence

Artificial Intelligence Briefing
6 min read
Media Mentions January 2026

Nick Manetto Discusses Future of Federal PBM Spread Pricing Bill With Inside Health Policy

1 min read
Podcast January 2026

Jennifer Breuer Discusses Latest Telehealth Developments on AHLA’s Speaking of Health Law Podcast

1 min read
Updates January 2026

State & Local Employment Law Developments: Q1 2026 (and Beyond)

New Employee Protections and Employer Obligations in California, Colorado, Connecticut, Delaware, District of Columbia, Illinois, Louisiana, Maine, Minnesota, Montana, New Hampshire, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, and Washington
18 min read
Media Mentions January 2026

Megan Herber and Nisha Quasba Discuss Reintroduction of NSGC’s Genetic Counseling Bill

2 min read
Updates January 2026

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Greater Clarity, Transparency, and Alignment in Digital Health Regulation
9 min read
Speaking Engagement Recap November 07, 2025

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Speaking Engagement Recap September 10, 2025

Understanding New PBM Laws and Drug Cost Developments Through Real-World Scenarios: Legal & Strategic Insights - Minneapolis, MN

2025 Health Law Institute
1 min read
News August 2025

Jonathan Keller and Helen Tuttle Recognized in 2025 New Jersey Legal Awards

1 min read
Press Release May 2025

Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD

2 min read
Insights
Updates February 2026

US and International Developments in Artificial Intelligence

Artificial Intelligence Briefing
6 min read
Media Mentions January 2026

Nick Manetto Discusses Future of Federal PBM Spread Pricing Bill With Inside Health Policy

1 min read
Podcast January 2026

Jennifer Breuer Discusses Latest Telehealth Developments on AHLA’s Speaking of Health Law Podcast

1 min read
Updates January 2026

State & Local Employment Law Developments: Q1 2026 (and Beyond)

New Employee Protections and Employer Obligations in California, Colorado, Connecticut, Delaware, District of Columbia, Illinois, Louisiana, Maine, Minnesota, Montana, New Hampshire, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, and Washington
18 min read
Media Mentions January 2026

Megan Herber and Nisha Quasba Discuss Reintroduction of NSGC’s Genetic Counseling Bill

2 min read
Updates January 2026

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Greater Clarity, Transparency, and Alignment in Digital Health Regulation
9 min read
Updates January 2026

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Federal Courts Demand Proper Purpose for DOJ Inquiries Into Gender-Affirming Treatments
9 min read
Updates December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read
Updates November 2025

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Artificial Intelligence Briefing
6 min read
Updates November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read

Meet The Team

Meet The Full Health Care Compliance & Regulatory Team